International Edition
Latest News
Health

Phenotypic ESBL Production and Beta-Lactamase Inhibitor Failure in Clinical Acinetobacter Isolates

A study from Krishna Hospital and Medical Research Centre found phenotypic extended-spectrum beta-lactamase (ESBL) production in 94.6% of 147 clinical Acinetobacter isolates, with beta-lactamase inhibitors failing to restore susceptibility. The cross-sectional analysis, published in Cureus, examined non-duplicate isolates…

ESBL-positive and multidrug-resistant prevalence rates, respectively

A study from Krishna Hospital and Medical Research Centre found phenotypic extended-spectrum beta-lactamase (ESBL) production in 94.6% of 147 clinical Acinetobacter isolates, with beta-lactamase inhibitors failing to restore susceptibility.

The cross-sectional analysis, published in Cureus, examined non-duplicate isolates collected between May 2025 and May 2026 at the Karad, India, tertiary care center. Researchers used the double-disc synergy test (DDST) and combined disc diffusion to screen for ESBLs, while Kirby-Bauer disk diffusion assessed susceptibility against 12 antimicrobial agents per CLSI M100 standards.

Acinetobacter baumannii complex dominated the cohort at 88.4% (130 isolates), followed by A. lwoffii at 8.8% (13 isolates), A. junii at 2.0% (3 isolates), and a single A. haemolyticus isolate.

ESBL positivity reached 96.9% in the A. baumannii complex, 92.3% in A. lwoffii, and 100% in the sole A. haemolyticus isolate.

Multidrug resistance (MDR), defined as non-susceptibility to at least one agent in three or more antimicrobial categories, was documented in 95.2% of all isolates. Resistance to six or more categories appeared in 77.6% of the collection.

Ceftazidime resistance stood at 92.5% (136 of 147 isolates). Adding clavulanic acid produced an identical resistance rate of 92.5%, yielding 0.0% net restoration of susceptibility.

Piperacillin resistance was 68.7% (101 isolates). The addition of tazobactam increased resistance to 89.1% (131 isolates), a statistically significant rise (p < 0.0001).

Non-baumannii Acinetobacter species — historically dismissed as low-virulence skin commensals — demonstrated high ESBL rates and MDR profiles comparable to the A. baumannii complex. The study notes these species are increasingly isolated from blood cultures, urine, and surgical site infections and are recognized as reservoirs for transferable resistance genes.

Karad, where Krishna Hospital is located, sits at the confluence of the Koyna and Krishna rivers in Maharashtra’s Satara district, a spot locally called Pritisangam. Once known as Karhatak, or “Elephant Market,” it served as the first capital of the Shilahara dynasty under Jatiga II before the seat moved to Kolhapur.

The city is widely recognized as the sugar bowl of Maharashtra for its concentration of sugar factories, and in 2020 it ranked as the cleanest town in the Swachh Survekshan survey for populations under one lakh. The 2011 census recorded a population of 74,355 for the town and surrounding villages.

Speciation relied on phenotypic and biochemical profiling, including growth at 44°C, citrate utilization, urease production, and beta-hemolysis. No automated mass spectrometry (MALDI-TOF MS) or molecular genotypic assays (PCR for blaTEM, blaSHV, blaCTX-M, blaPER, blaVEB) were performed. The DDST and combined disc diffusion criteria are formally standardized for Enterobacterales, not Acinetobacter, and were applied as complementary screening tools.

Polymyxins (colistin) and ampicillin/sulbactam were excluded from the routine disc diffusion panel. Extensive drug resistance (XDR) was defined using a panel-adapted criterion of non-susceptibility across five to seven of the seven tested categories.

The Institutional Ethics Committee approved the protocol (Ref. No. KVV/IEC/03/2025, Protocol Number: 689/2024-2025). Written informed consent was waived for anonymized isolates obtained during routine diagnostics.

About the author: Health Desk

Health Desk at Archynewsy.